Corpus Engine Towards a reproducible .science file.
← All .science files

pmid:26285647

4-protein signature predicting tamoxifen treatment outcome in recurrent breast cancer.

Tommaso De Marchi · Ning Qing Liu · Cristoph Stingl · Mieke A Timmermans · Marcel Smid · Maxime P Look · Mila Tjoa · Rene B H Braakman · Mark Opdam · Sabine C Linn · Fred C G J Sweep · Paul N Span · Mike Kliffen · Theo M Luider · John A Foekens · John W M Martens · Arzu Umar

Molecular oncology · 2016 doi:10.1016/j.molonc.2015.07.004

Paper

complete

Experiment

partial

Data

partial

Analysis

partial

Execution

absent

Execution evidence has not yet been added to this .science file. Explore its methods, data and open questions to plan the next step.
Record details sci_version · id · kind · revision · content_hash · schema · created_at · updated_at · generator
id
pmid:26285647
kind
science-record
content_hash
sha256:c16de92a946099af930b633fd71d80dae9734a456a085d53adc6e7522b96da59
schema
https://corpus.bntrg.co.uk/sci/1.0/sci.schema.json
created_at
2026-11-01T15:40:10Z
updated_at
2026-11-01T21:58:34Z
generator object · 2 fields
name
corpus-assay-engine
run_id
reading-sci-2026-11-01
paper object · 10 fields
state
complete
title
4-protein signature predicting tamoxifen treatment outcome in recurrent breast cancer.
doi
10.1016/j.molonc.2015.07.004
pmid
26285647
authors array · 17 items
[0]
Tommaso De Marchi
[1]
Ning Qing Liu
[2]
Cristoph Stingl
[3]
Mieke A Timmermans
[4]
Marcel Smid
[5]
Maxime P Look
[6]
Mila Tjoa
[7]
Rene B H Braakman
[8]
Mark Opdam
[9]
Sabine C Linn
[10]
Fred C G J Sweep
[11]
Paul N Span
[12]
Mike Kliffen
[13]
Theo M Luider
[14]
John A Foekens
[15]
John W M Martens
[16]
Arzu Umar
journal
Molecular oncology
year
2016
abstract
Estrogen receptor (ER) positive tumors represent the majority of breast malignancies, and are effectively treated with hormonal therapies, such as tamoxifen. However, in the recurrent disease resistance to tamoxifen therapy is common and a major cause of death. In recent years, in-depth proteome analyses have enabled identification of clinically useful biomarkers, particularly, when heterogeneity in complex tumor tissue was reduced using laser capture microdissection (LCM). In the current study, we performed high resolution proteomic analysis on two cohorts of ER positive breast tumors derived from patients who either manifested good or poor outcome to tamoxifen treatment upon recurrence. A total of 112 fresh frozen tumors were collected from multiple medical centers and divided into two sets: an in-house training and a multi-center test set. Epithelial tumor cells were enriched with LCM and analyzed by nano-LC Orbitrap mass spectrometry (MS), which yielded >3000 and >4000 quantified proteins in the training and test sets, respectively. Raw data are available via ProteomeXchange with identifiers PXD000484 and PXD000485. Statistical analysis showed differential abundance of 99 proteins, of which a subset of 4 proteins was selected through a multivariate step-down to develop a predictor for tamoxifen treatment outcome. The 4-protein signature significantly predicted poor outcome patients in the test set, independent of predictive histopathological characteristics (hazard ratio [HR] = 2.17; 95% confidence interval [CI] = 1.15 to 4.17; multivariate Cox regression p value = 0.017). Immunohistochemical (IHC) staining of PDCD4, one of the signature proteins, on an independent set of formalin-fixed paraffin-embedded tumor tissues provided and independent technical validation (HR = 0.72; 95% CI = 0.57 to 0.92; multivariate Cox regression p value = 0.009). We hereby report the first validated protein predictor for tamoxifen treatment outcome in recurrent ER-positive breast cancer. IHC further showed that PDCD4 is an independent marker.
claims array · 2 items
[0] object · 6 fields
id
claim-method
statement
Student t test (p value < 0.05) was then used to assess differences in protein expression levels between good and poor outcome patients.
kind
methodological
target
null
evidence array · 1 item
[0] object · 3 fields
asset
source:pmid:26285647
locator
sections[4] "Sample sets" paragraph 3
quote
Student t test (p value < 0.05) was then used to assess differences in protein expression levels between good and poor outcome patients.
state
complete
[1] object · 6 fields
id
claim-data-access
statement
Raw data are available via ProteomeXchange with identifiers PXD000484 and PXD000485.
kind
methodological
target
null
evidence array · 1 item
[0] object · 3 fields
asset
source:pmid:26285647
locator
sections[0] "Abstract" paragraph 1
quote
Raw data are available via ProteomeXchange with identifiers PXD000484 and PXD000485.
state
complete
gaps array · 0 items
experiment object · 8 fields
state
partial
objective
The study used Student’s t-test followed by multivariate Cox regression with a step-down approach to develop and validate a four-protein tamoxifen-outcome signature; proteomic source data were generated from LCM-enriched tumors by nano-LC Orbitrap mass spectrometry and deposited in ProteomeXchange under PXD000484 and PXD000485.
steps array · 3 items
[0] object · 13 fields
id
read_published_estimate
order
1
name
Read the published estimate from the source
kind
other
state
complete
blocked_on
null
description
The claim, method and evidence span published with the source article.
parameters object · 0 fields
inputs array · 1 item
[0]
source:pmid:26285647
outputs array · 1 item
[0]
the published estimate and its evidence
instruments array · 0 items
reagents array · 0 items
[1] object · 13 fields
id
obtain_source_data
order
2
name
Obtain the source data from the named repository
kind
data-preparation
state
blocked
blocked_on
data:accession_absent
description
The GEO series accession resolves and its sample accessions are listed. This lane did not download the dataset or read its licence.
parameters object · 0 fields
inputs array · 0 items
outputs array · 1 item
[0]
the source data with its repository provenance
instruments array · 0 items
reagents array · 0 items
[2] object · 13 fields
id
run_analysis
order
3
name
Run the published analysis
kind
analysis
state
blocked
blocked_on
method:student_t
description
Apply the paper's statistical method to the resolved series and compare the result with the published target.
parameters object · 1 field
p_value
Student t test (p value < 0
inputs array · 0 items
outputs array · 1 item
[0]
the replicated result and its comparison
instruments array · 0 items
reagents array · 0 items
materials array · 0 items
instruments array · 0 items
reagents array · 0 items
conditions object · 0 fields
gaps array · 2 items
[0]
step:run_analysis blocked on method:student_t
[1]
step:obtain_source_data blocked on data:accession_absent
data object · 3 fields
state
partial
assets array · 6 items
[0] object · 15 fields
id
source:pmid:26285647
role
manuscript
format
xml
media_type
application/xml
uri
https://doi.org/10.1016/j.molonc.2015.07.004
sha256
sha256:81ab1071b27d253d596127fd4db0bdd9d4463963e22c5682ad9aed94c85c8581
bytes
51632
access
open
state
resolved
reader
null
reader_status
reader_required
identifier
10.1016/j.molonc.2015.07.004
version
null
note
Full article fetched from PMC; the checksum covers the rendered section body, not the original XML bytes.
structure object · 4 fields
pmcid
PMC5528925
source
europe_pmc_fulltext
coverage
whole_body_without_references
text_hash_scope
rendered_section_body
[1] object · 16 fields
id
asset:table:pmid:26285647:1
role
table
format
jats-table
media_type
application/vnd.jats.table+json
uri
null
sha256
sha256:44ea46f1995a64afbc485aa59493f57e5d9ed4fe59afef8ec46cf94a700868f4
bytes
1424
access
open
state
verified
reader
read_table
reader_status
available
identifier
section[4]/table-wrap[1]#mol2201610124-tbl-0001
version
null
note
Patient and tumor characteristics.
structure object · 5 fields
pmcid
PMC5528925
section_index
4
section_title
Sample sets
row_count
33
column_count
4
table object · 8 fields
label
Table Table 1
caption
Patient and tumor characteristics.
rows array · 33 items
[0] array · 3 items
[0]
[1]
Traininga
[2]
Testa
[1] array · 3 items
[0]
EMC
[1]
NKI‐AVL
[2]
RadboudUMC
[2] array · 4 items
[0]
All patients
[1]
56 (100)
[2]
41 (100)
[3]
15 (100)
[3] array · 1 item
[0]
Age
[4] array · 4 items
[0]
≤ 55 years
[1]
15 (27)
[2]
12 (29)
[3]
1 (7)
[5] array · 4 items
[0]
> 55 years
[1]
41 (73)
[2]
29 (71)
[3]
14 (93)
[6] array · 1 item
[0]
Menopausal status
[7] array · 4 items
[0]
Premenopausal
[1]
10 (18)
[2]
11 (27)
[3]
0 (0)
[8] array · 4 items
[0]
Postmenopausal
[1]
46 (82)
[2]
30 (63)
[3]
15 (100)
[9] array · 1 item
[0]
Tumor size
[10] array · 4 items
[0]
T1 (≤2 cm)
[1]
12 (21)
[2]
20 (49)
[3]
5 (33)
[11] array · 4 items
[0]
T2 (2–5 cm) + Tx
[1]
40 (72)
[2]
19 (46)
[3]
9 (60)
[12] array · 4 items
[0]
T3 (>5 cm) + T4
[1]
4 (7)
[2]
2 (5)
[3]
1 (7)
[13] array · 1 item
[0]
Tumor differentiationb
[14] array · 4 items
[0]
Good/Moderate
[1]
13 (59)
[2]
29 (71)
[3]
8 (53)
[15] array · 4 items
[0]
Poor
[1]
33 (23)
[2]
12 (29)
[3]
4 (27)
[16] array · 4 items
[0]
Unknown
[1]
10 (18)
[2]
0 (0)
[3]
3 (20)
[17] array · 1 item
[0]
Disease free interval
[18] array · 4 items
[0]
≤ 12 months
[1]
24 (43)
[2]
4 (10)
[3]
5 (33)
[19] array · 4 items
[0]
> 12 months
[1]
32 (57)
[2]
37 (90)
[3]
10 (67)
[20] array · 1 item
[0]
PgRc
[21] array · 4 items
[0]
Negative
[1]
9 (16)
[2]
17 (41)
[3]
11 (73)
[22] array · 4 items
[0]
Positive
[1]
44 (79)
[2]
24 (59)
[3]
4 (27)
[23] array · 1 item
[0]
Involved lymph nodes
[24] array · 4 items
[0]
0
[1]
31 (55)
[2]
24 (58)
[3]
6 (40)
[25] array · 4 items
[0]
≥ 1
[1]
20 (36)
[2]
16 (39)
[3]
7 (47)
[26] array · 4 items
[0]
unknown
[1]
5 (9)
[2]
1 (3)
[3]
2 (13)
[27] array · 1 item
[0]
Dominant site of relapse
[28] array · 4 items
[0]
Loco‐regional
[1]
8 (14)
[2]
4 (10)
[3]
0 (0)
[29] array · 4 items
[0]
Bone
[1]
26 (46)
[2]
12 (29)
[3]
6 (40)
[30] array · 4 items
[0]
Visceral
[1]
13 (24)
[2]
6 (15)
[3]
9 (60)
[31] array · 4 items
[0]
Bone and other
[1]
9 (16)
[2]
14 (34)
[3]
0 (0)
[32] array · 4 items
[0]
Unknown
[1]
0 (0)
[2]
5 (12)
[3]
0 (0)
locator
section[4]/table-wrap[1]#mol2201610124-tbl-0001
[2] object · 16 fields
id
asset:table:pmid:26285647:2
role
table
format
jats-table
media_type
application/vnd.jats.table+json
uri
null
sha256
sha256:c544d6dc87fdcec134d720551504ed04bce207b89c7d4dad889adf8c7df16745
bytes
821
access
open
state
verified
reader
read_table
reader_status
available
identifier
section[17]/table-wrap[1]#mol2201610124-tbl-0002
version
null
note
LFQ based identification of 4 proteins in discovery and validation sets.
structure object · 5 fields
pmcid
PMC5528925
section_index
17
section_title
Development of a protein signature predictive of tamoxifen therapy outcome
row_count
6
column_count
9
table object · 8 fields
label
Table Table 2
caption
LFQ based identification of 4 proteins in discovery and validation sets.
rows array · 6 items
[0] array · 6 items
[0]
Protein ID
[1]
Gene name
[2]
Molecular weight (kDa)
[3]
Peptides/Unique peptidesa
[4]
Sequence coverage/Unique sequence coverage (%/%)b
[5]
PEP scorec
[1] array · 6 items
[0]
Training
[1]
Test
[2]
Training
[3]
Test
[4]
Training
[5]
Test
[2] array · 9 items
[0]
Q9P2M7
[1]
CGN
[2]
136.380
[3]
22/22
[4]
40/40
[5]
22.8/22.8
[6]
39.5/39.5
[7]
3.63E‐133
[8]
7.88E‐268
[3] array · 9 items
[0]
Q9UN86
[1]
G3BP2
[2]
54.120
[3]
5/5
[4]
8/7
[5]
16.4/16.4
[6]
22.0/19.5
[7]
1.61E‐34
[8]
5.85E‐84
[4] array · 9 items
[0]
Q9NX40
[1]
OCIAD1
[2]
27.626
[3]
8/8
[4]
9/9
[5]
32.2/32.2
[6]
32.7/32.7
[7]
5.35E‐146
[8]
2.59E‐247
[5] array · 9 items
[0]
Q53EL6
[1]
PDCD4
[2]
51.735
[3]
19/19
[4]
18/18
[5]
49.3/49.3
[6]
47.8/47.8
[7]
1.24E‐225
[8]
3.23E‐281
locator
section[17]/table-wrap[1]#mol2201610124-tbl-0002
[3] object · 16 fields
id
asset:table:pmid:26285647:3
role
table
format
jats-table
media_type
application/vnd.jats.table+json
uri
null
sha256
sha256:618eac5f5a3f65c5a7dc73bf56a6d2b4c8b7419c3c71278e84b4f141b483c655
bytes
682
access
open
state
verified
reader
read_table
reader_status
available
identifier
section[17]/table-wrap[2]#mol2201610124-tbl-0003
version
null
note
Information on the 4 proteins constituting the predictor for tamoxifen therapy outcome.
structure object · 5 fields
pmcid
PMC5528925
section_index
17
section_title
Development of a protein signature predictive of tamoxifen therapy outcome
row_count
5
column_count
5
table object · 8 fields
label
Table Table 3
caption
Information on the 4 proteins constituting the predictor for tamoxifen therapy outcome.
rows array · 5 items
[0] array · 5 items
[0]
Gene name
[1]
GO cellular component
[2]
Protein name
[3]
Student t
[4]
p value
[1] array · 5 items
[0]
CGN
[1]
Cell junction
[2]
Cingulin
[3]
3.13
[4]
0.006
[2] array · 5 items
[0]
G3BP2
[1]
Cytoplasm
[2]
Ras GTPase‐activating protein‐binding protein 2
[3]
3.50
[4]
<0.001
[3] array · 5 items
[0]
OCIAD1
[1]
Endosome, Mitochondrion
[2]
Ovarian carcinoma immunogenic antigen domain‐containing protein 1
[3]
4.15
[4]
<0.001
[4] array · 5 items
[0]
PDCD4
[1]
Cytoplasm, Nucleus
[2]
Programmed cell death protein 4
[3]
3.99
[4]
<0.001
locator
section[17]/table-wrap[2]#mol2201610124-tbl-0003
[4] object · 16 fields
id
asset:table:pmid:26285647:4
role
table
format
jats-table
media_type
application/vnd.jats.table+json
uri
null
sha256
sha256:dbbee7ba44858ba90057e9da4a0a18b04d2748b81ae2901cd6a770af97bb68cb
bytes
1063
access
open
state
verified
reader
read_table
reader_status
available
identifier
section[17]/table-wrap[3]#mol2201610124-tbl-0004
version
null
note
Univariate and multivariate Cox regression analysis for time to progression.
structure object · 5 fields
pmcid
PMC5528925
section_index
17
section_title
Development of a protein signature predictive of tamoxifen therapy outcome
row_count
18
column_count
7
table object · 8 fields
label
Table Table 4
caption
Univariate and multivariate Cox regression analysis for time to progression.
rows array · 18 items
[0] array · 7 items
[0]
Factors
[1]
Hazard ratio
[2]
Univariate 95% CI
[3]
p value
[4]
Hazard ratio
[5]
Multivariate 95% CI
[6]
p value
[1] array · 1 item
[0]
4 protein predictor score
[2] array · 7 items
[0]
High
[1]
1.00
[2]
[3]
[4]
1.00
[5]
[6]
[3] array · 7 items
[0]
Low
[1]
2.44
[2]
1.30–4.54
[3]
0.006
[4]
2.17
[5]
1.15–4.17
[6]
0.017
[4] array · 1 item
[0]
Age
[5] array · 7 items
[0]
≤55 years
[1]
1.00
[2]
[3]
[4]
1.00
[5]
[6]
[6] array · 7 items
[0]
>55 years
[1]
0.44
[2]
0.23–0.86
[3]
0.017
[4]
0.55
[5]
0.28–1.08
[6]
0.083
[7] array · 1 item
[0]
Disease free interval
[8] array · 7 items
[0]
≤12 months
[1]
1.00
[2]
[3]
[4]
[5]
[6]
[9] array · 7 items
[0]
>12 months
[1]
0.63
[2]
0.30–1.31
[3]
0.213
[4]
[5]
[6]
[10] array · 7 items
[0]
Dominant site of relapse
[1]
[2]
[3]
Overall p
[4]
[5]
[6]
[11] array · 7 items
[0]
Loco‐regional
[1]
1.00
[2]
[3]
0.270
[4]
[5]
[6]
[12] array · 7 items
[0]
Bone
[1]
0.89
[2]
0.30–2.68
[3]
[4]
[5]
[6]
[13] array · 7 items
[0]
Visceral
[1]
0.68
[2]
0.22–2.09
[3]
[4]
[5]
[6]
[14] array · 7 items
[0]
Bone and other
[1]
0.45
[2]
0.14–1.40
[3]
[4]
[5]
[6]
[15] array · 1 item
[0]
PgR
[16] array · 7 items
[0]
Negative
[1]
1.00
[2]
[3]
[4]
[5]
[6]
[17] array · 7 items
[0]
Positive
[1]
0.57
[2]
0.32–1.00
[3]
0.052
[4]
[5]
[6]
locator
section[17]/table-wrap[3]#mol2201610124-tbl-0004
[5] object · 16 fields
id
asset:table:pmid:26285647:5
role
table
format
jats-table
media_type
application/vnd.jats.table+json
uri
null
sha256
sha256:c7d3e8ec4751e2c1431f1b40303e6263f15d9cad527e76208ae095e53b56748a
bytes
1057
access
open
state
verified
reader
read_table
reader_status
available
identifier
section[18]/table-wrap[1]#mol2201610124-tbl-0005
version
null
note
Univariate and multivariate Cox regression analysis for time to progression.
structure object · 5 fields
pmcid
PMC5528925
section_index
18
section_title
Immunohistochemical assessment of PDCD4 expression and correlation with TTP
row_count
18
column_count
7
table object · 8 fields
label
Table Table 5
caption
Univariate and multivariate Cox regression analysis for time to progression.
rows array · 18 items
[0] array · 7 items
[0]
Factors
[1]
Hazard ratio
[2]
Univariate 95% CI
[3]
p value
[4]
Hazard ratio
[5]
Multivariate 95% CI
[6]
p value
[1] array · 1 item
[0]
PDCD4
[2] array · 7 items
[0]
Low
[1]
1.00
[2]
[3]
[4]
1.00
[5]
[6]
[3] array · 7 items
[0]
High
[1]
0.75
[2]
0.59–0.96
[3]
0.020
[4]
0.72
[5]
0.57–0.92
[6]
0.009
[4] array · 1 item
[0]
Age
[5] array · 7 items
[0]
≤55
[1]
1.00
[2]
[3]
[4]
1.00
[5]
[6]
[6] array · 7 items
[0]
>55
[1]
0.58
[2]
0.45–0.70
[3]
<0.001
[4]
0.52
[5]
0.40–0.67
[6]
<0.001
[7] array · 1 item
[0]
Disease free interval
[8] array · 7 items
[0]
≤12 months
[1]
1.00
[2]
[3]
[4]
1.00
[5]
[6]
[9] array · 7 items
[0]
>12 months
[1]
0.73
[2]
0.54–0.99
[3]
0.042
[4]
0.63
[5]
0.46–0.87
[6]
0.004
[10] array · 7 items
[0]
Dominant site of relapse
[1]
[2]
[3]
Overall p
[4]
[5]
[6]
[11] array · 7 items
[0]
Loco‐regional
[1]
1.00
[2]
[3]
0.310
[4]
[5]
[6]
[12] array · 7 items
[0]
Bone
[1]
1.39
[2]
0.91–2.10
[3]
[4]
[5]
[6]
[13] array · 7 items
[0]
Visceral
[1]
1.15
[2]
0.73–1.81
[3]
[4]
[5]
[6]
[14] array · 7 items
[0]
Bone and other
[1]
1.38
[2]
0.89–2.13
[3]
[4]
[5]
[6]
[15] array · 1 item
[0]
PgR
[16] array · 7 items
[0]
Negative
[1]
1.00
[2]
[3]
[4]
[5]
[6]
[17] array · 7 items
[0]
Positive
[1]
0.77
[2]
0.59–1.01
[3]
0.062
[4]
[5]
[6]
locator
section[18]/table-wrap[1]#mol2201610124-tbl-0005
gaps array · 0 items
analysis object · 4 fields
state
partial
methods array · 7 items
[0] object · 10 fields
id
method-1
family
group_comparison
specific
student_t_test
label
Group comparison
dsl_operations array · 0 items
missing_operations array · 1 item
[0]
student_t
expressible
false
parameters object · 1 field
p_value
Student t test (p value < 0
data_shapes array · 1 item
[0]
two_or_more_groups_continuous
evidence object · 3 fields
score
0.8
band
high
quote
Student t test
[1] object · 10 fields
id
method-2
family
survival_analysis
specific
cox_proportional_hazards
label
Survival analysis
dsl_operations array · 1 item
[0]
cox_ph
missing_operations array · 0 items
parameters object · 1 field
p_value
ivariate Cox regression p value = 0
data_shapes array · 1 item
[0]
time_to_event_with_censoring
evidence object · 3 fields
score
0.7
band
medium
quote
Cox regression
[2] object · 10 fields
id
method-3
family
regression_modelling
specific
logistic
label
Regression modelling
dsl_operations array · 1 item
[0]
glm_logit_fit
missing_operations array · 0 items
parameters object · 0 fields
data_shapes array · 1 item
[0]
predictors_and_outcome
evidence object · 3 fields
score
0.8
band
high
quote
logistic regression
[3] object · 10 fields
id
method-4
family
correlation_analysis
specific
pearson
label
Correlation analysis
dsl_operations array · 1 item
[0]
pearson_r
missing_operations array · 0 items
parameters object · 0 fields
data_shapes array · 1 item
[0]
paired_numeric_columns
evidence object · 3 fields
score
0.8
band
high
quote
Pearson correlation
[4] object · 10 fields
id
method-5
family
clustering
specific
hierarchical
label
Clustering
dsl_operations array · 1 item
[0]
hierarchical_cluster
missing_operations array · 0 items
parameters object · 0 fields
data_shapes array · 1 item
[0]
feature_matrix
evidence object · 3 fields
score
0.8
band
high
quote
Hierarchical clustering
[5] object · 10 fields
id
method-6
family
contingency_analysis
specific
chi_square
label
Categorical (contingency table) analysis
dsl_operations array · 1 item
[0]
chi_square_test
missing_operations array · 0 items
parameters object · 0 fields
data_shapes array · 1 item
[0]
categorical_cross_tabulation
evidence object · 3 fields
score
0.8
band
high
quote
χ2
[6] object · 10 fields
id
method-7
family
null
specific
null
label
Student’s t test
dsl_operations array · 0 items
missing_operations array · 0 items
parameters object · 0 fields
data_shapes array · 0 items
evidence object · 3 fields
score
1
band
verbatim
quote
Student t test (p value < 0.05) was then used to assess differences in protein expression levels between good and poor outcome patients.
targets array · 1 item
[0] object · 8 fields
id
target-published-estimate
claim_id
claim-target-result
operation
chi_square_test
unit
p-value
tolerance
null
state
complete
note
The threshold the paper applied to its own result, as the paper states it. A run that reproduces the effect is judged against this threshold.
gaps array · 2 items
[0]
method.reader_named_unmapped
[1]
method.student_t
capability object · 3 fields
state
complete
requirements array · 1 item
[0] object · 6 fields
capability_id
capability:computational_analysis
label
Computational analysis platform
assay_families array · 9 items
[0]
meta_analysis
[1]
machine_learning
[2]
survival_analysis
[3]
statistical_regression
[4]
pca
[5]
molecular_docking
[6]
network_analysis
[7]
differential_expression
[8]
gwas
candidate
Automated Assays Laravel application and simulated adapters
gaps array · 0 items
readiness object · 8 fields
state
blocked
tier
R4
blocked_on
data:accession_absent
axes object · 3 fields
method object · 5 fields
tier
R1
expressible
false
required_operations array · 0 items
missing_operations array · 1 item
[0]
student_t
basis
The paper names the method it used and the corpus's method extractor maps it onto the DSL catalogue: student_t_test.
capability object · 4 fields
tier
R1
capability_id
capability:computational_analysis
availability_state
owned
basis
The computational analysis is owned. The physical bench the paper used is not, so a physical validation cannot be run here.
data object · 6 fields
tier
R4
reachable
false
accessions array · 1 item
[0]
PXD000484 and PXD000485
resolved_accessions array · 0 items
statements array · 1 item
[0]
Raw data are available via ProteomeXchange with identifiers PXD000484 and PXD000485.
basis
The paper names PXD000484 and PXD000485, but the accession does not resolve in the repository (no reason recorded), so the data cannot be reached from here. No dataset was downloaded and no licence was read.
can_run object · 3 fields
dsl_operations array · 0 items
assets array · 6 items
[0]
source:pmid:26285647
[1]
asset:table:pmid:26285647:1
[2]
asset:table:pmid:26285647:2
[3]
asset:table:pmid:26285647:3
[4]
asset:table:pmid:26285647:4
[5]
asset:table:pmid:26285647:5
steps array · 0 items
must_build object · 5 fields
dsl_operations array · 1 item
[0] object · 3 fields
operation
student_t
priority
null
converters array · 0 items
readers array · 0 items
capabilities array · 0 items
data_gaps array · 1 item
[0]
data:geo:None
gaps array · 1 item
[0]
data:accession_absent
review object · 5 fields
state
partial
machine_critique object · 5 fields
kind
extraction_review
reader object · 5 fields
model
MiniMax-M3.1-Flash
provider
minimax
provider_family
minimax
read_at
2026-10-31T18:24:30Z
independence
same_provider
evidence_check object · 2 fields
method
verbatim
availability
verbatim
calls
8
usage object · 3 fields
prompt_tokens
96989
completion_tokens
3490
cached_tokens
1568
stages array · 1 item
[0] object · 4 fields
id
extraction
state
complete
reader
MiniMax-M3.1-Flash
provider
minimax
gaps array · 3 items
[0]
review.independent_reader
[1]
review.machine_critique
[2]
review.human_critique
execution object · 5 fields
state
absent
status
not_run
mode
null
runs array · 0 items
gaps array · 1 item
[0]
execution.not_run
provenance object · 7 fields
entities array · 3 items
[0] object · 3 fields
id
pmid:26285647
type
paper
label
pmid:26285647
[1] object · 3 fields
id
source:pmid:26285647
type
manuscript
label
PMID 26285647 full text
[2] object · 3 fields
id
data:geo:None
type
dataset
label
GEO None
activities array · 3 items
[0] object · 4 fields
id
activity-reading-sci-2026-11-01
type
classification
used array · 3 items
[0] object · 3 fields
id
pmid:26285647
type
paper
label
pmid:26285647
[1] object · 3 fields
id
source:pmid:26285647
type
manuscript
label
PMID 26285647 full text
[2] object · 3 fields
id
data:geo:None
type
dataset
label
GEO None
agent
agent:corpus-assay-engine
[1] object · 4 fields
id
activity-read-26285647
type
extraction
used array · 1 item
[0]
source:pmid:26285647
agent
agent:minimax-reader
[2] object · 4 fields
id
activity-resolve-None
type
accession_resolution
used array · 1 item
[0]
data:geo:None
agent
agent:corpus-assay-engine
agents array · 2 items
[0] object · 3 fields
id
agent:corpus-assay-engine
type
software
label
Corpus assay engine
[1] object · 3 fields
id
agent:minimax-reader
type
software
label
MiniMax literature reader
source_run_id
reading-sci-2026-11-01
dsl_catalogue_fingerprint
343fb30756ba6ec3
capability_table_fingerprint
2cb3e42f047d2ecf
snapshot_id
ba34b49490d9bfaf
lineage object · 4 fields
parent_id
pmid:26285647
parent_hash
sha256:48dae0723cf64983f21383910157a6517da2884460b83eb76dc32c1524916bc1
fork_of
null
gaps array · 8 items
[0]
execution.not_run
[1]
method.reader_named_unmapped
[2]
method.student_t
[3]
review.human_critique
[4]
review.independent_reader
[5]
review.machine_critique
[6]
step:obtain_source_data blocked on data:accession_absent
[7]
step:run_analysis blocked on method:student_t
assays array · 3 items
[0] object · 11 fields
role
data_generation
definition_id
mass_spectrometry
definition_version
99e1195c7d6f
required_operations array · 0 items
support_state
partial
source_hashes object · 1 field
assay_lexicon
99e1195c7d6f
confidence
0.99
evidence array · 4 items
[0]
ed with LCM and analyzed by nano-LC Orbitrap mass spectrometry (MS), which yielded >3000 and >4000 quantifi
[1]
current study, we performed high resolution proteomic analysis on two cohorts of ER positive breas
[2]
nt cohorts and separately measured by LC‐MS. Proteomic data from training and test sets were analyz
[3]
ing data (10 minimum observations for global proteomic analysis and allowing 30% and 0% missing dat
order_basis
paper_text_order:573
id
assay:1
[1] object · 11 fields
role
data_generation
definition_version
99e1195c7d6f
required_operations array · 0 items
support_state
partial
source_hashes object · 1 field
assay_lexicon
99e1195c7d6f
confidence
0.99
evidence array · 4 items
[0]
ultivariate Cox regression p value = 0.017). Immunohistochemical (IHC) staining of PDCD4, one of the signatur
[1]
ssion p value = 0.017). Immunohistochemical (IHC) staining of PDCD4, one of the signature pro
[2]
come in recurrent ER-positive breast cancer. IHC further showed that PDCD4 is an independent
[3]
e polymerase chain reaction (RadboudUMC), or IHC (NKI‐AVL). All patients underwent surgery of
order_basis
paper_text_order:1646
id
assay:2
[2] object · 11 fields
role
analysis
definition_id
group_comparison
definition_version
f2132e96ae6c7a4e
required_operations array · 0 items
support_state
partial
source_hashes object · 1 field
dsl_catalogue
f2132e96ae6c7a4e
evidence array · 1 item
[0]
Student t test
order_basis
consumes_earlier_output
id
assay:3
Complete file
{"sci_version": "1.2", "schema": "https://corpus.bntrg.co.uk/sci/1.0/sci.schema.json", "id": "pmid:26285647", "kind": "science-record", "revision": 7, "content_hash": "sha256:c16de92a946099af930b633fd71d80dae9734a456a085d53adc6e7522b96da59", "created_at": "2026-11-01T15:40:10Z", "updated_at": "2026-11-01T21:58:34Z", "generator": {"name": "corpus-assay-engine", "run_id": "reading-sci-2026-11-01"}, "paper": {"state": "complete", "title": "4-protein signature predicting tamoxifen treatment outcome in recurrent breast cancer.", "doi": "10.1016/j.molonc.2015.07.004", "pmid": "26285647", "authors": ["Tommaso De Marchi", "Ning Qing Liu", "Cristoph Stingl", "Mieke A Timmermans", "Marcel Smid", "Maxime P Look", "Mila Tjoa", "Rene B H Braakman", "Mark Opdam", "Sabine C Linn", "Fred C G J Sweep", "Paul N Span", "Mike Kliffen", "Theo M Luider", "John A Foekens", "John W M Martens", "Arzu Umar"], "journal": "Molecular oncology", "year": 2016, "abstract": "Estrogen receptor (ER) positive tumors represent the majority of breast malignancies, and are effectively treated with hormonal therapies, such as tamoxifen. However, in the recurrent disease resistance to tamoxifen therapy is common and a major cause of death. In recent years, in-depth proteome analyses have enabled identification of clinically useful biomarkers, particularly, when heterogeneity in complex tumor tissue was reduced using laser capture microdissection (LCM). In the current study, we performed high resolution proteomic analysis on two cohorts of ER positive breast tumors derived from patients who either manifested good or poor outcome to tamoxifen treatment upon recurrence. A total of 112 fresh frozen tumors were collected from multiple medical centers and divided into two sets: an in-house training and a multi-center test set. Epithelial tumor cells were enriched with LCM and analyzed by nano-LC Orbitrap mass spectrometry (MS), which yielded >3000 and >4000 quantified proteins in the training and test sets, respectively. Raw data are available via ProteomeXchange with identifiers PXD000484 and PXD000485. Statistical analysis showed differential abundance of 99 proteins, of which a subset of 4 proteins was selected through a multivariate step-down to develop a predictor for tamoxifen treatment outcome. The 4-protein signature significantly predicted poor outcome patients in the test set, independent of predictive histopathological characteristics (hazard ratio [HR] = 2.17; 95% confidence interval [CI] = 1.15 to 4.17; multivariate Cox regression p value = 0.017). Immunohistochemical (IHC) staining of PDCD4, one of the signature proteins, on an independent set of formalin-fixed paraffin-embedded tumor tissues provided and independent technical validation (HR = 0.72; 95% CI = 0.57 to 0.92; multivariate Cox regression p value = 0.009). We hereby report the first validated protein predictor for tamoxifen treatment outcome in recurrent ER-positive breast cancer. IHC further showed that PDCD4 is an independent marker.", "claims": [{"id": "claim-method", "statement": "Student t test (p value < 0.05) was then used to assess differences in protein expression levels between good and poor outcome patients.", "kind": "methodological", "target": null, "evidence": [{"asset": "source:pmid:26285647", "locator": "sections[4] \"Sample sets\" paragraph 3", "quote": "Student t test (p value < 0.05) was then used to assess differences in protein expression levels between good and poor outcome patients."}], "state": "complete"}, {"id": "claim-data-access", "statement": "Raw data are available via ProteomeXchange with identifiers PXD000484 and PXD000485.", "kind": "methodological", "target": null, "evidence": [{"asset": "source:pmid:26285647", "locator": "sections[0] \"Abstract\" paragraph 1", "quote": "Raw data are available via ProteomeXchange with identifiers PXD000484 and PXD000485."}], "state": "complete"}], "gaps": []}, "experiment": {"state": "partial", "objective": "The study used Student’s t-test followed by multivariate Cox regression with a step-down approach to develop and validate a four-protein tamoxifen-outcome signature; proteomic source data were generated from LCM-enriched tumors by nano-LC Orbitrap mass spectrometry and deposited in ProteomeXchange under PXD000484 and PXD000485.", "steps": [{"id": "read_published_estimate", "order": 1, "name": "Read the published estimate from the source", "kind": "other", "state": "complete", "blocked_on": null, "description": "The claim, method and evidence span published with the source article.", "duration_hours": null, "parameters": {}, "inputs": ["source:pmid:26285647"], "outputs": ["the published estimate and its evidence"], "instruments": [], "reagents": []}, {"id": "obtain_source_data", "order": 2, "name": "Obtain the source data from the named repository", "kind": "data-preparation", "state": "blocked", "blocked_on": "data:accession_absent", "description": "The GEO series accession resolves and its sample accessions are listed. This lane did not download the dataset or read its licence.", "duration_hours": null, "parameters": {}, "inputs": [], "outputs": ["the source data with its repository provenance"], "instruments": [], "reagents": []}, {"id": "run_analysis", "order": 3, "name": "Run the published analysis", "kind": "analysis", "state": "blocked", "blocked_on": "method:student_t", "description": "Apply the paper's statistical method to the resolved series and compare the result with the published target.", "duration_hours": null, "parameters": {"p_value": "Student t test (p value < 0"}, "inputs": [], "outputs": ["the replicated result and its comparison"], "instruments": [], "reagents": []}], "materials": [], "instruments": [], "reagents": [], "conditions": {}, "gaps": ["step:run_analysis blocked on method:student_t", "step:obtain_source_data blocked on data:accession_absent"]}, "data": {"state": "partial", "assets": [{"id": "source:pmid:26285647", "role": "manuscript", "format": "xml", "media_type": "application/xml", "uri": "https://doi.org/10.1016/j.molonc.2015.07.004", "sha256": "sha256:81ab1071b27d253d596127fd4db0bdd9d4463963e22c5682ad9aed94c85c8581", "bytes": 51632, "access": "open", "state": "resolved", "reader": null, "reader_status": "reader_required", "identifier": "10.1016/j.molonc.2015.07.004", "version": null, "note": "Full article fetched from PMC; the checksum covers the rendered section body, not the original XML bytes.", "structure": {"pmcid": "PMC5528925", "source": "europe_pmc_fulltext", "coverage": "whole_body_without_references", "text_hash_scope": "rendered_section_body"}}, {"id": "asset:table:pmid:26285647:1", "role": "table", "format": "jats-table", "media_type": "application/vnd.jats.table+json", "uri": null, "sha256": "sha256:44ea46f1995a64afbc485aa59493f57e5d9ed4fe59afef8ec46cf94a700868f4", "bytes": 1424, "access": "open", "state": "verified", "reader": "read_table", "reader_status": "available", "identifier": "section[4]/table-wrap[1]#mol2201610124-tbl-0001", "version": null, "note": "Patient and tumor characteristics.", "structure": {"pmcid": "PMC5528925", "section_index": 4, "section_title": "Sample sets", "row_count": 33, "column_count": 4}, "table": {"label": "Table Table 1", "caption": "Patient and tumor characteristics.", "rows": [["", "Traininga", "Testa"], ["EMC", "NKI‐AVL", "RadboudUMC"], ["All patients", "56 (100)", "41 (100)", "15 (100)"], ["Age"], ["≤ 55 years", "15 (27)", "12 (29)", "1 (7)"], ["> 55 years", "41 (73)", "29 (71)", "14 (93)"], ["Menopausal status"], ["Premenopausal", "10 (18)", "11 (27)", "0 (0)"], ["Postmenopausal", "46 (82)", "30 (63)", "15 (100)"], ["Tumor size"], ["T1 (≤2 cm)", "12 (21)", "20 (49)", "5 (33)"], ["T2 (2–5 cm) + Tx", "40 (72)", "19 (46)", "9 (60)"], ["T3 (>5 cm) + T4", "4 (7)", "2 (5)", "1 (7)"], ["Tumor differentiationb"], ["Good/Moderate", "13 (59)", "29 (71)", "8 (53)"], ["Poor", "33 (23)", "12 (29)", "4 (27)"], ["Unknown", "10 (18)", "0 (0)", "3 (20)"], ["Disease free interval"], ["≤ 12 months", "24 (43)", "4 (10)", "5 (33)"], ["> 12 months", "32 (57)", "37 (90)", "10 (67)"], ["PgRc"], ["Negative", "9 (16)", "17 (41)", "11 (73)"], ["Positive", "44 (79)", "24 (59)", "4 (27)"], ["Involved lymph nodes"], ["0", "31 (55)", "24 (58)", "6 (40)"], ["≥ 1", "20 (36)", "16 (39)", "7 (47)"], ["unknown", "5 (9)", "1 (3)", "2 (13)"], ["Dominant site of relapse"], ["Loco‐regional", "8 (14)", "4 (10)", "0 (0)"], ["Bone", "26 (46)", "12 (29)", "6 (40)"], ["Visceral", "13 (24)", "6 (15)", "9 (60)"], ["Bone and other", "9 (16)", "14 (34)", "0 (0)"], ["Unknown", "0 (0)", "5 (12)", "0 (0)"]], "row_count": 33, "column_count": 4, "numeric_cells": 78, "header_rows": 2, "locator": "section[4]/table-wrap[1]#mol2201610124-tbl-0001"}}, {"id": "asset:table:pmid:26285647:2", "role": "table", "format": "jats-table", "media_type": "application/vnd.jats.table+json", "uri": null, "sha256": "sha256:c544d6dc87fdcec134d720551504ed04bce207b89c7d4dad889adf8c7df16745", "bytes": 821, "access": "open", "state": "verified", "reader": "read_table", "reader_status": "available", "identifier": "section[17]/table-wrap[1]#mol2201610124-tbl-0002", "version": null, "note": "LFQ based identification of 4 proteins in discovery and validation sets.", "structure": {"pmcid": "PMC5528925", "section_index": 17, "section_title": "Development of a protein signature predictive of tamoxifen therapy outcome", "row_count": 6, "column_count": 9}, "table": {"label": "Table Table 2", "caption": "LFQ based identification of 4 proteins in discovery and validation sets.", "rows": [["Protein ID", "Gene name", "Molecular weight (kDa)", "Peptides/Unique peptidesa", "Sequence coverage/Unique sequence coverage (%/%)b", "PEP scorec"], ["Training", "Test", "Training", "Test", "Training", "Test"], ["Q9P2M7", "CGN", "136.380", "22/22", "40/40", "22.8/22.8", "39.5/39.5", "3.63E‐133", "7.88E‐268"], ["Q9UN86", "G3BP2", "54.120", "5/5", "8/7", "16.4/16.4", "22.0/19.5", "1.61E‐34", "5.85E‐84"], ["Q9NX40", "OCIAD1", "27.626", "8/8", "9/9", "32.2/32.2", "32.7/32.7", "5.35E‐146", "2.59E‐247"], ["Q53EL6", "PDCD4", "51.735", "19/19", "18/18", "49.3/49.3", "47.8/47.8", "1.24E‐225", "3.23E‐281"]], "row_count": 6, "column_count": 9, "numeric_cells": 31, "header_rows": 2, "locator": "section[17]/table-wrap[1]#mol2201610124-tbl-0002"}}, {"id": "asset:table:pmid:26285647:3", "role": "table", "format": "jats-table", "media_type": "application/vnd.jats.table+json", "uri": null, "sha256": "sha256:618eac5f5a3f65c5a7dc73bf56a6d2b4c8b7419c3c71278e84b4f141b483c655", "bytes": 682, "access": "open", "state": "verified", "reader": "read_table", "reader_status": "available", "identifier": "section[17]/table-wrap[2]#mol2201610124-tbl-0003", "version": null, "note": "Information on the 4 proteins constituting the predictor for tamoxifen therapy outcome.", "structure": {"pmcid": "PMC5528925", "section_index": 17, "section_title": "Development of a protein signature predictive of tamoxifen therapy outcome", "row_count": 5, "column_count": 5}, "table": {"label": "Table Table 3", "caption": "Information on the 4 proteins constituting the predictor for tamoxifen therapy outcome.", "rows": [["Gene name", "GO cellular component", "Protein name", "Student t", "p value"], ["CGN", "Cell junction", "Cingulin", "3.13", "0.006"], ["G3BP2", "Cytoplasm", "Ras GTPase‐activating protein‐binding protein 2", "3.50", "<0.001"], ["OCIAD1", "Endosome, Mitochondrion", "Ovarian carcinoma immunogenic antigen domain‐containing protein 1", "4.15", "<0.001"], ["PDCD4", "Cytoplasm, Nucleus", "Programmed cell death protein 4", "3.99", "<0.001"]], "row_count": 5, "column_count": 5, "numeric_cells": 11, "header_rows": 1, "locator": "section[17]/table-wrap[2]#mol2201610124-tbl-0003"}}, {"id": "asset:table:pmid:26285647:4", "role": "table", "format": "jats-table", "media_type": "application/vnd.jats.table+json", "uri": null, "sha256": "sha256:dbbee7ba44858ba90057e9da4a0a18b04d2748b81ae2901cd6a770af97bb68cb", "bytes": 1063, "access": "open", "state": "verified", "reader": "read_table", "reader_status": "available", "identifier": "section[17]/table-wrap[3]#mol2201610124-tbl-0004", "version": null, "note": "Univariate and multivariate Cox regression analysis for time to progression.", "structure": {"pmcid": "PMC5528925", "section_index": 17, "section_title": "Development of a protein signature predictive of tamoxifen therapy outcome", "row_count": 18, "column_count": 7}, "table": {"label": "Table Table 4", "caption": "Univariate and multivariate Cox regression analysis for time to progression.", "rows": [["Factors", "Hazard ratio", "Univariate 95% CI", "p value", "Hazard ratio", "Multivariate 95% CI", "p value"], ["4 protein predictor score"], ["High", "1.00", "", "", "1.00", "", ""], ["Low", "2.44", "1.30–4.54", "0.006", "2.17", "1.15–4.17", "0.017"], ["Age"], ["≤55 years", "1.00", "", "", "1.00", "", ""], [">55 years", "0.44", "0.23–0.86", "0.017", "0.55", "0.28–1.08", "0.083"], ["Disease free interval"], ["≤12 months", "1.00", "", "", "", "", ""], [">12 months", "0.63", "0.30–1.31", "0.213", "", "", ""], ["Dominant site of relapse", "", "", "Overall p", "", "", ""], ["Loco‐regional", "1.00", "", "0.270", "", "", ""], ["Bone", "0.89", "0.30–2.68", "", "", "", ""], ["Visceral", "0.68", "0.22–2.09", "", "", "", ""], ["Bone and other", "0.45", "0.14–1.40", "", "", "", ""], ["PgR"], ["Negative", "1.00", "", "", "", "", ""], ["Positive", "0.57", "0.32–1.00", "0.052", "", "", ""]], "row_count": 18, "column_count": 7, "numeric_cells": 39, "header_rows": 1, "locator": "section[17]/table-wrap[3]#mol2201610124-tbl-0004"}}, {"id": "asset:table:pmid:26285647:5", "role": "table", "format": "jats-table", "media_type": "application/vnd.jats.table+json", "uri": null, "sha256": "sha256:c7d3e8ec4751e2c1431f1b40303e6263f15d9cad527e76208ae095e53b56748a", "bytes": 1057, "access": "open", "state": "verified", "reader": "read_table", "reader_status": "available", "identifier": "section[18]/table-wrap[1]#mol2201610124-tbl-0005", "version": null, "note": "Univariate and multivariate Cox regression analysis for time to progression.", "structure": {"pmcid": "PMC5528925", "section_index": 18, "section_title": "Immunohistochemical assessment of PDCD4 expression and correlation with TTP", "row_count": 18, "column_count": 7}, "table": {"label": "Table Table 5", "caption": "Univariate and multivariate Cox regression analysis for time to progression.", "rows": [["Factors", "Hazard ratio", "Univariate 95% CI", "p value", "Hazard ratio", "Multivariate 95% CI", "p value"], ["PDCD4"], ["Low", "1.00", "", "", "1.00", "", ""], ["High", "0.75", "0.59–0.96", "0.020", "0.72", "0.57–0.92", "0.009"], ["Age"], ["≤55", "1.00", "", "", "1.00", "", ""], [">55", "0.58", "0.45–0.70", "<0.001", "0.52", "0.40–0.67", "<0.001"], ["Disease free interval"], ["≤12 months", "1.00", "", "", "1.00", "", ""], [">12 months", "0.73", "0.54–0.99", "0.042", "0.63", "0.46–0.87", "0.004"], ["Dominant site of relapse", "", "", "Overall p", "", "", ""], ["Loco‐regional", "1.00", "", "0.310", "", "", ""], ["Bone", "1.39", "0.91–2.10", "", "", "", ""], ["Visceral", "1.15", "0.73–1.81", "", "", "", ""], ["Bone and other", "1.38", "0.89–2.13", "", "", "", ""], ["PgR"], ["Negative", "1.00", "", "", "", "", ""], ["Positive", "0.77", "0.59–1.01", "0.062", "", "", ""]], "row_count": 18, "column_count": 7, "numeric_cells": 42, "header_rows": 1, "locator": "section[18]/table-wrap[1]#mol2201610124-tbl-0005"}}], "gaps": []}, "analysis": {"state": "partial", "methods": [{"id": "method-1", "family": "group_comparison", "specific": "student_t_test", "label": "Group comparison", "dsl_operations": [], "missing_operations": ["student_t"], "expressible": false, "parameters": {"p_value": "Student t test (p value < 0"}, "data_shapes": ["two_or_more_groups_continuous"], "evidence": {"score": 0.8, "band": "high", "quote": "Student t test"}}, {"id": "method-2", "family": "survival_analysis", "specific": "cox_proportional_hazards", "label": "Survival analysis", "dsl_operations": ["cox_ph"], "missing_operations": [], "expressible": true, "parameters": {"p_value": "ivariate Cox regression p value = 0"}, "data_shapes": ["time_to_event_with_censoring"], "evidence": {"score": 0.7, "band": "medium", "quote": "Cox regression"}}, {"id": "method-3", "family": "regression_modelling", "specific": "logistic", "label": "Regression modelling", "dsl_operations": ["glm_logit_fit"], "missing_operations": [], "expressible": true, "parameters": {}, "data_shapes": ["predictors_and_outcome"], "evidence": {"score": 0.8, "band": "high", "quote": "logistic regression"}}, {"id": "method-4", "family": "correlation_analysis", "specific": "pearson", "label": "Correlation analysis", "dsl_operations": ["pearson_r"], "missing_operations": [], "expressible": true, "parameters": {}, "data_shapes": ["paired_numeric_columns"], "evidence": {"score": 0.8, "band": "high", "quote": "Pearson correlation"}}, {"id": "method-5", "family": "clustering", "specific": "hierarchical", "label": "Clustering", "dsl_operations": ["hierarchical_cluster"], "missing_operations": [], "expressible": true, "parameters": {}, "data_shapes": ["feature_matrix"], "evidence": {"score": 0.8, "band": "high", "quote": "Hierarchical clustering"}}, {"id": "method-6", "family": "contingency_analysis", "specific": "chi_square", "label": "Categorical (contingency table) analysis", "dsl_operations": ["chi_square_test"], "missing_operations": [], "expressible": true, "parameters": {}, "data_shapes": ["categorical_cross_tabulation"], "evidence": {"score": 0.8, "band": "high", "quote": "χ2"}}, {"id": "method-7", "family": null, "specific": null, "label": "Student’s t test", "dsl_operations": [], "missing_operations": [], "expressible": null, "parameters": {}, "data_shapes": [], "evidence": {"score": 1.0, "band": "verbatim", "quote": "Student t test (p value < 0.05) was then used to assess differences in protein expression levels between good and poor outcome patients."}}], "targets": [{"id": "target-published-estimate", "claim_id": "claim-target-result", "operation": "chi_square_test", "expected_value": 0.01, "unit": "p-value", "tolerance": null, "state": "complete", "note": "The threshold the paper applied to its own result, as the paper states it. A run that reproduces the effect is judged against this threshold."}], "gaps": ["method.reader_named_unmapped", "method.student_t"]}, "capability": {"state": "complete", "requirements": [{"capability_id": "capability:computational_analysis", "label": "Computational analysis platform", "assay_families": ["meta_analysis", "machine_learning", "survival_analysis", "statistical_regression", "pca", "molecular_docking", "network_analysis", "differential_expression", "gwas"], "availability_state": "owned", "tier_unlocked": "R1", "candidate": "Automated Assays Laravel application and simulated adapters"}], "gaps": []}, "readiness": {"state": "blocked", "tier": "R4", "blocking_axis": "data", "blocked_on": "data:accession_absent", "axes": {"method": {"tier": "R1", "expressible": false, "required_operations": [], "missing_operations": ["student_t"], "basis": "The paper names the method it used and the corpus's method extractor maps it onto the DSL catalogue: student_t_test."}, "capability": {"tier": "R1", "capability_id": "capability:computational_analysis", "availability_state": "owned", "basis": "The computational analysis is owned. The physical bench the paper used is not, so a physical validation cannot be run here."}, "data": {"tier": "R4", "reachable": false, "accessions": ["PXD000484 and PXD000485"], "resolved_accessions": [], "statements": ["Raw data are available via ProteomeXchange with identifiers PXD000484 and PXD000485."], "basis": "The paper names PXD000484 and PXD000485, but the accession does not resolve in the repository (no reason recorded), so the data cannot be reached from here. No dataset was downloaded and no licence was read."}}, "can_run": {"dsl_operations": [], "assets": ["source:pmid:26285647", "asset:table:pmid:26285647:1", "asset:table:pmid:26285647:2", "asset:table:pmid:26285647:3", "asset:table:pmid:26285647:4", "asset:table:pmid:26285647:5"], "steps": []}, "must_build": {"dsl_operations": [{"operation": "student_t", "unlocks_papers": null, "priority": null}], "converters": [], "readers": [], "capabilities": [], "data_gaps": ["data:geo:None"]}, "gaps": ["data:accession_absent"]}, "review": {"state": "partial", "machine_critique": {"kind": "extraction_review", "reader": {"model": "MiniMax-M3.1-Flash", "provider": "minimax", "provider_family": "minimax", "read_at": "2026-10-31T18:24:30Z", "independence": "same_provider"}, "evidence_check": {"method": "verbatim", "availability": "verbatim"}, "calls": 8, "usage": {"prompt_tokens": 96989, "completion_tokens": 3490, "cached_tokens": 1568}}, "human_critique": null, "stages": [{"id": "extraction", "state": "complete", "reader": "MiniMax-M3.1-Flash", "provider": "minimax"}], "gaps": ["review.independent_reader", "review.machine_critique", "review.human_critique"]}, "execution": {"state": "absent", "status": "not_run", "mode": null, "runs": [], "gaps": ["execution.not_run"]}, "provenance": {"entities": [{"id": "pmid:26285647", "type": "paper", "label": "pmid:26285647"}, {"id": "source:pmid:26285647", "type": "manuscript", "label": "PMID 26285647 full text"}, {"id": "data:geo:None", "type": "dataset", "label": "GEO None"}], "activities": [{"id": "activity-reading-sci-2026-11-01", "type": "classification", "used": [{"id": "pmid:26285647", "type": "paper", "label": "pmid:26285647"}, {"id": "source:pmid:26285647", "type": "manuscript", "label": "PMID 26285647 full text"}, {"id": "data:geo:None", "type": "dataset", "label": "GEO None"}], "agent": "agent:corpus-assay-engine"}, {"id": "activity-read-26285647", "type": "extraction", "used": ["source:pmid:26285647"], "agent": "agent:minimax-reader"}, {"id": "activity-resolve-None", "type": "accession_resolution", "used": ["data:geo:None"], "agent": "agent:corpus-assay-engine"}], "agents": [{"id": "agent:corpus-assay-engine", "type": "software", "label": "Corpus assay engine"}, {"id": "agent:minimax-reader", "type": "software", "label": "MiniMax literature reader"}], "source_run_id": "reading-sci-2026-11-01", "dsl_catalogue_fingerprint": "343fb30756ba6ec3", "capability_table_fingerprint": "2cb3e42f047d2ecf", "snapshot_id": "ba34b49490d9bfaf"}, "lineage": {"parent_id": "pmid:26285647", "parent_hash": "sha256:48dae0723cf64983f21383910157a6517da2884460b83eb76dc32c1524916bc1", "fork_of": null, "generation": 6}, "gaps": ["execution.not_run", "method.reader_named_unmapped", "method.student_t", "review.human_critique", "review.independent_reader", "review.machine_critique", "step:obtain_source_data blocked on data:accession_absent", "step:run_analysis blocked on method:student_t"], "assays": [{"role": "data_generation", "definition_id": "mass_spectrometry", "definition_version": "99e1195c7d6f", "definition_digest": null, "required_operations": [], "support_state": "partial", "source_hashes": {"assay_lexicon": "99e1195c7d6f"}, "confidence": 0.99, "evidence": ["ed with LCM and analyzed by nano-LC Orbitrap mass spectrometry (MS), which yielded >3000 and >4000 quantifi", "current study, we performed high resolution proteomic analysis on two cohorts of ER positive breas", "nt cohorts and separately measured by LC‐MS. Proteomic data from training and test sets were analyz", "ing data (10 minimum observations for global proteomic analysis and allowing 30% and 0% missing dat"], "order_basis": "paper_text_order:573", "id": "assay:1"}, {"role": "data_generation", "definition_id": "ihc", "definition_version": "99e1195c7d6f", "definition_digest": null, "required_operations": [], "support_state": "partial", "source_hashes": {"assay_lexicon": "99e1195c7d6f"}, "confidence": 0.99, "evidence": ["ultivariate Cox regression p value = 0.017). Immunohistochemical (IHC) staining of PDCD4, one of the signatur", "ssion p value = 0.017). Immunohistochemical (IHC) staining of PDCD4, one of the signature pro", "come in recurrent ER-positive breast cancer. IHC further showed that PDCD4 is an independent", "e polymerase chain reaction (RadboudUMC), or IHC (NKI‐AVL). All patients underwent surgery of"], "order_basis": "paper_text_order:1646", "id": "assay:2"}, {"role": "analysis", "definition_id": "group_comparison", "definition_version": "f2132e96ae6c7a4e", "definition_digest": null, "required_operations": [], "support_state": "partial", "source_hashes": {"dsl_catalogue": "f2132e96ae6c7a4e"}, "confidence": 0.8, "evidence": ["Student t test"], "order_basis": "consumes_earlier_output", "id": "assay:3"}]}